|
|
基于Gensini评分探究血清TNC水平、NHR比值与冠状动脉病变程度的相关性
|
Abstract:
目的：探究冠心病人群中血清肌腱蛋白C (TNC)、中性粒细胞计数/高密度脂蛋白胆固醇(NHR)与冠状动脉病变严重程度的相关性及联合预测价值。方法：选取2023年12月至2024年6月于承德市中心医院住院行冠状动脉造影(CAG)检查确诊冠心病的患者119例为研究对象(冠心病组)，以同期行冠状动脉造影检查阴性的患者69例为非冠心病组。比较两组患者的基线资料、血清TNC水平、NHR比值的差异性。根据冠脉病变程度将冠心病组又分为轻度狭窄组(67例)、中度狭窄组(29例)、重度狭窄组(23例)，比较三组间基线资料、血清TNC水平、NHR比值的差异性。分析血清TNC水平、NHR比值与其冠状动脉病变严重程度的相关性及其预测价值。结果：冠心病组患者血清TNC水平、NHR比值明显高于非冠心病组(P < 0.05)。不同狭窄程度的亚组之间比较，重度狭窄组患者血清TNC水平、NHR比值显著超过了轻、中度狭窄组(P < 0.05)，中度狭窄组患者血清TNC水平、NHR比值明显高于轻度狭窄组(P < 0.05)。Spearman相关性分析表明，冠心病患者血清TNC水平、NHR比值与冠状动脉狭窄程度之间存在着显著正相关关系(r = 0.589, r = 0.493, P < 0.01)。多因素Logistic回归分析显示血清TNC (OR: 1.330, 95% CI: 1.168~1.514, P < 0.001)、NHR (OR: 2.097, 95% CI: 1.420~3.095, P < 0.001)是冠状动脉中重度狭窄的独立危险因素。ROC曲线显示血清TNC水平、NHR比值预测冠状动脉中重度狭窄的AUC分别为0.792、0.763，二者联合预测冠状动脉中重度狭窄的AUC为0.852。联合预测的AUC明显大于TNC、NHR各自单独预测的AUC (Z = 2.126, Z = 2.479, P < 0.05)。结论：血清TNC水平、NHR比值与冠心病患者的冠状动脉狭窄程度呈正相关，两者对预测冠心病及冠状动脉中重度狭窄有一定的价值，联合预测优于单一指标预测。
Objective: In a population with coronary heart disease, to examine the relationship and combined predictive value of serum Tenascin-C (TNC), serum neutrophil to high-density lipoprotein cholesterol ratio (NHR), and the severity of coronary artery lesions. Methods: 119 individuals having coronary angiography (CAG) diagnoses of coronary heart disease in Chengde Central Hospital from December 2023 to June 2024 were chosen as research participants (coronary heart disease group). As a control group, 69 individuals with negative coronary artery disease were chosen. According to the severity of coronary artery lesions, the coronary heart disease group was split up into a mild stenosis group (67 cases), a moderate stenosis group (29 cases), and a severe stenosis group (23 cases). The study aimed to compare the baseline data, serum TNC levels, and NHR ratios difference among the three groups. To analyze the correlation among the severity of coronary artery lesions and the serum TNC levels and NHR ratios of the patients. Additionally, to determine the predictive value of these measures. Results: Serum TNC levels and the NHR ratio were significantly higher in the coronary heart disease (CHD) group compared to the non-CHD group (P < 0.05). Furthermore, when comparing subgroups based on stenosis severity, serum TNC levels and the NHR ratio in the severe stenosis group significantly exceeded those in the mild and moderate stenosis groups (P < 0.05). Serum TNC levels and the NHR ratio were also significantly
| [1] | Tsao, C.W., Aday, A.W., Almarzooq, Z.I., et al. (2023) Heart Disease and Stroke Statistics—2023 Update: A Report from the American Heart Association. Circulation, 147, e93-e621. https://doi.org/10.1161/CIR.0000000000001137 |
| [2] | Imanaka-Yoshida, K., Tawara, I. and Yoshida, T. (2020) Tenascin-C in Cardiac Disease: A Sophisticated Controller of Inflammation, Repair, and Fibrosis. American Journal of Physiology-Cell Physiology, 319, C781-C796. https://doi.org/10.1152/ajpcell.00353.2020 |
| [3] | Iyoda, T., Ohishi, A., Wang, Y., Yokoyama, M., Kazama, M., Okita, N., et al. (2024) Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation. International Journal of Molecular Sciences, 25, Article 1825. https://doi.org/10.3390/ijms25031825 |
| [4] | Podesser, B.K., Kreibich, M., Dzilic, E., Santer, D., Förster, L., Trojanek, S., et al. (2018) Tenascin-C Promotes Chronic Pressure Overload-Induced Cardiac Dysfunction, Hypertrophy and Myocardial Fibrosis. Journal of Hypertension, 36, 847-856. https://doi.org/10.1097/hjh.0000000000001628 |
| [5] | Gholipour, A., Shakerian, F., Zahedmehr, A., Oveisee, M., Maleki, M., Mowla, S.J., et al. (2022) Tenascin-C as a Noninvasive Biomarker of Coronary Artery Disease. Molecular Biology Reports, 49, 9267-9273. https://doi.org/10.1007/s11033-022-07760-z |
| [6] | Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. https://doi.org/10.1038/s41586-021-03392-8 |
| [7] | Silvestre-Roig, C., Braster, Q., Ortega-Gomez, A. and Soehnlein, O. (2020) Neutrophils as Regulators of Cardiovascular Inflammation. Nature Reviews Cardiology, 17, 327-340. https://doi.org/10.1038/s41569-019-0326-7 |
| [8] | Schoch, L., Alcover, S., Padró, T., Ben-Aicha, S., Mendieta, G., Badimon, L., et al. (2023) Update of HDL in Atherosclerotic Cardiovascular Disease. Clínica e Investigación en Arteriosclerosis, 35, 297-314. https://doi.org/10.1016/j.arteri.2023.10.002 |
| [9] | 中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694. |
| [10] | 中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 中华急诊医学杂志, 2019, 28(4): 421-428. |
| [11] | Rampidis, G.P., Benetos, G., Benz, D.C., Giannopoulos, A.A. and Buechel, R.R. (2019) A guide for Gensini Score calculation. Atherosclerosis, 287, 181-183. https://doi.org/10.1016/j.atherosclerosis.2019.05.012 |
| [12] | Marzeda, A.M. and Midwood, K.S. (2018) Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity. Journal of Histochemistry & Cytochemistry, 66, 289-304. https://doi.org/10.1369/0022155418757443 |
| [13] | Shi, X., Zhu, S., Liu, M., Stone, S.S., Rong, Y., Mao, K., et al. (2022) Single-Cell RNA-Seq Reveals a Population of Smooth Muscle Cells Responsible for Atherogenesis. Aging and disease, 13, 1939-1953. https://doi.org/10.14336/ad.2022.0313 |
| [14] | Schaff, M., Receveur, N., Bourdon, C., Wurtz, V., Denis, C.V., Orend, G., et al. (2011) Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation under Flow. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 117-124. https://doi.org/10.1161/atvbaha.110.206375 |
| [15] | Kimura, T., Tajiri, K., Sato, A., Sakai, S., Wang, Z., Yoshida, T., et al. (2018) Tenascin-c Accelerates Adverse Ventricular Remodelling after Myocardial Infarction by Modulating Macrophage Polarization. Cardiovascular Research, 115, 614-624. https://doi.org/10.1093/cvr/cvy244 |
| [16] | Li, Y., Liu, J., Huang, J., Song, J., Ma, Z. and Shi, H. (2018) In Vivo MRI Detection of Atherosclerosis in Apoe-Deficient Mice by Using Tenascin-C-Targeted Uspio. Acta Radiologica, 59, 1431-1437. https://doi.org/10.1177/0284185118762613 |
| [17] | Gao, W., Li, J., Ni, H., Shi, H., Qi, Z., Zhu, S., et al. (2019) Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 26, 31-38. https://doi.org/10.5551/jat.42887 |
| [18] | Xu, S., Zhang, T., Cao, Z., Zhong, W., Zhang, C., Li, H., et al. (2021) Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights. Frontiers in Immunology, 12, Article 638400. https://doi.org/10.3389/fimmu.2021.638400 |
| [19] | Sasmita, B.R., Zhu, Y., Gan, H., Hu, X., Xue, Y., Xiang, Z., et al. (2021) Leukocyte and Its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study. Shock, 57, 351-359. https://doi.org/10.1097/shk.0000000000001876 |
| [20] | Güven, R., Akyol, K.C., Bayar, N., et al. (2018) Neutrophil Count as a Predictor of Critical Coronary Artery Stenosis in Young Patients. Iranian Journal of Public Health, 47, 765-767. |
| [21] | Ozgeyik, M. and Ozgeyik, M.O. (2021) Long-Term Prognosis after Treatment of Total Occluded Coronary Artery Is Well Predicted by Neutrophil to High-Density Lipoprotein Ratio: A Comparison Study. Kardiologiia, 61, 60-67. https://doi.org/10.18087/cardio.2021.7.n1637 |
